Periodontitis, AdultNCT07596667
Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial
A study testing scaling and root planing in people with Periodontitis, Adult and Periodontal Diseases, run by Zeyad Nazar.
Trial summary
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Periodontitis, Adult, Periodontal Diseases
- What is being tested?
- scaling and root planing
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 21 participants
- Where
- No sites listed yet
- Study dates
- 15 Jul 2026to 1 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- patients over 18 years old
- patients with periodontal pockets depth more than 4 mm
Who cannot join
- Pregnant women
- patients taking antibiotic within the last three months
- Patients with systemic disease ( Diabetes mellitus)
About this study
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Read the detailed description
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Keywords: periodontal diseases; periodontal debridement; dental polishing; periodontal pocket
Why is this important?
This research explained the effects of non surgical periodontal treatment for patients with periodontal disease on the epithelial tissue regeneration during the healing process.
Introduction Periodontitis is a destructive disease of tooth-supporting tissues which initiated in response to frank dysbiosis of dental biofilm complemented by aggravated immune response. The hallmark of periodontitis is pathologic deepening of gingival sulci which are transformed into periodontal pockets when the front of dental biofilm advances apically. In such situation, immune responses are initiated within gingival tissue in order to counterattack the pathobionts and its virulent products . Polymorph nuclear cells, mainly neutrophils, are among the principle immune system components responsible for this task via series of biological activities such as phagocytosis and netosis. Prolonged inflammation of periodontal lesions and continuous heavy recruitment of these inflammatory cells leads to the release of oxygen free radicals (ROS) in an escalating pace which overwhelm antioxidant capacity of the host . Overproduction of ROS trigger series of destructive events characterized by increased metabolites of lipid peroxidation, DNA damage and protein damage that led to tissues damage . This shift of oxidative-antioxidant balance towards oxidative stress leads to dramatic changes in the levels of oxidative stress-related molecules such as total antioxidant capacity (TAC) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) . These biomarkers can be clinically detected in oral biofluids such as saliva and GCF with a potential to discriminate between periodontal health and disease .
In healthy periodontium, the gingival sulcus is lined by sulcular epithelium which is continued with the junctional epithelium at sulcus base. The epithelial cells are adherent to each other by range of junctional attachment including desmosomes, adherens junctions, and tight junctions. The integrity of this coherent epithelial cells provides a physical barrier against the ingress of pathobionts to deeper tissues or systemic circulation. Adherens junctions is the predominant cellular junctions which structurally composed of E-cadherin that grouped in extracellular, transmembrane, and intracellular domains. β-catenin forms a complex with E-cadherin, mediating the attachment of intracellular domain of adherens junctions to the cytoskeleton . Persistent inflammation associated with excessive oxidative stress culminating in the tissue compromises epithelial barrier function . Damage of E-cadherin-β-catenin complex leads to the release of β-catenin and its subsequent nuclear translocation; thereby, activating Wnt signaling pathway which is responsible for compromising epithelial phenotype . This notion is supported by detecting elevated level of β-catenin in GCF samples collected from periodontitis patients associated with clinical attachment loss (CAL) in comparison to healthy controls .
The goal of periodontal therapy is to preserve and maintain natural dentition as well as improve oral and systemic health. Non-surgical periodontal therapy (NSPT) considered as gold standard decision to remove biofilm and reduce pathobionts load to restore symbiotic state of oral microbiome and tissue homeostasis . Demand of Successful periodontal therapy depends on improvement in clinical parameters in the term of bleeding on probing (BOP), probing pocket depth (PPD) and CAL . Therefore, this study aimed to track changes in the level GCF of β-catenin ,8-OHdG, and TAC and investigate the association between these biomarkers during the healing period.
Materials and methods Study design This study is a clinical trial involving periodontitis patients who will followed for up to 3 months. The study will conducted from June 2026 to September 2026. The participants will be selected from the pool of patients attending the clinics in the College of Dentistry, University of Babylon. The volunteered patients should sign consent form, which will be collected by the examiner.
Inclusion and exclusion criteria The patients should be ≥ 18 years, have no history of systemic disease, have unstable periodontitis at any stage and grade with at least one moderately deep periodontal pocket (4 - 6 mm) at a single-rooted tooth. The patients were excluded when they were smokers, pregnant or lactating, taking medications which might influence the healing such as corticosteroids and calcium channel blockers, having previous periodontal therapy within the last 3 months, or using antibiotics within 3 months prior to enrolment.
Sample size The required sample size for this study was estimated after considering a reduction in probing pocket depth (PPD) from 7.64 ±1.76 mm to 5.68 ±2.3 mm in shallow pockets [12]. By using G*Power software 3.1, it was estimated that a sample of 17 patients was enough for rejecting the null hypothesis at a power of 0.8 and probability margin of error of 0.05. An extra four patients were invited to participate in this study to avoid any dropout during the follow-up.
Clinical examination and procedure At baseline visit (T0), the selected patients will diagnosed with unstable periodontitis which will defined by the presence of interdental clinical attachment loss (CAL) at ≥ 2 non-adjacent teeth and PPD > 5 mm or 4 mm pockets with bleeding on probing (BOP). In absence of interdental CAL, patients having buccal or oral CAL ≥ 3 mm with PPD > 3 mm detectable at ≥ 2 teeth were also diagnosed as periodontitis [13]. After diagnosis, plaque Index (PI) will used to record presence/absence of dental plaque on 4 sites/tooth with the aid of disclosing agent (EMS®, Switzerland) [14]. Then, BOP, PPD and CAL will recorded at 6 sites/tooth using UNC-15 periodontal probe (PHOENIX®, UK) by a calibrated examiner.
GCF samples will collected from randomly selected sites with periodontal pockets of 4 -6 mm after recording the clinical parameters. Each site will dried using cotton and air blowing by triple syringe. A paper strip (Oraflow Inc.®, New York, USA) will inserted into the selected pocket until feeling slight resistance. After 30 seconds, this pre-weighted paper strip will removed and immediately immersed in an Eppendorf tube (CNWTC/OEM, Jiangsu, China) containing 200 µl phosphate buffer saline (PBS) [15]. Then, the tube containing the strip and PBS will weighted using an electronic balance (JOANLAB®, China). The GCF weight will estimated by subtracting the weight of the tube containing the strip and PBS after sampling from the weights of the dry strip and the tube with PBS before sampling the GCF. Then, the tubes containing GCF samples will saved at -20 °C until further analysis.
After GCF samples collection, patients will receive professional mechanical plaque removal (PMPR) using ultrasonic scaler by the same examiner. Finally, oral hygiene instructions will given to all patients including tooth brushing twice a day and interdental cleaning with an appropriate tool such as interdental brush and dental floss. One week later, root surface debridement (RSD) will performed for all sites with pockets with Gracey curettes (Sakura, YDM®, Japan). Then, all teeth will polished by rubber cups and prophylaxis paste. After 4 weeks (T1) and 12 weeks (T2), all clinical parameters will recorded and GCF samples will recollected as describe above by the same examiner.
Enzyme-linked immunosorbent assay The frozen GCF samples will thawed at room temperature and centrifuged at 4000 RPM for 5 min (Rotofix® 32A, Germany). The optical density will measured at 450 nm and the operator who performed the procedures will blinded to the tested groups. Concentration of 8-OHdG was quantified competitive inhibition enzyme immunoassay technique (USCN®, USA). Sensitivity values was 26.81 pg/ml, with a detection range of 74.07-6.000 pg./ml. ELISA-based sandwich technique will used for quantitative measurement of β-catenin kit (USCN®, USA) with sensitivity values was 5.9 pg./ml and detection range of15.6-1.000 pg/ml. Colorimetric assay facilitated by an ELISA TAC kit (Elabscience®, USA) sensitivity value was 0.62 U/ml with detection range 0.62-190.43 U/ml.
Statistical analysis Data will analyzed using Prism 9 for macOS (Version 9.1.1) and IBM SPSS Statistics (Version 27). Data will presented as frequency, percentage or means (SD). The normality of continuous data will tested using Shapiro-Wilk test. Comparisons among means of variables at different time points will carried out using Friedman test. Dunn's test was used for Post hoc comparison between means of variables at two time points with consideration of adjusting considered p value. Pearson test and linear regression will used to assess the association and possible interactions between the study variables. The significance level will set at p value < 0.05.
- Conditions
- Periodontitis, Adult, Periodontal Diseases
- Being tested
- scaling and root planing
- Keywords
- periodontitis, non surgical periodontal therapy
- Medical subject headings
- Chronic Periodontitis, Periodontal Diseases, Periodontitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
scaling and root planingProcedure or surgery
Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
| Study group | Role | What they receive |
|---|---|---|
| periodontitis patients with pocket depth | Experimental | Not described Receives: Procedure: scaling and root planing |
What is being measured
The primary outcome is the main question the study is designed to answer.
periodontal pocket depth
periodontal pocket depth reduction
Measured: 3 months
measurement of probing pocket depth (PPD)
measuring probing pocket depth (PPD)
Measured: 3 months
measurement of clinical attachment loss (CAL)
clinical attachment loss (CAL)
Measured: 3 months
Secondary outcomes (1)
GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA) in which all have the same measuring units
GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA) after 3 months
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start15 Jul 2026 (estimated)
- Primary completion15 Nov 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Periodontitis, AdultStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Periodontitis patients (n = 21) will be included in this clinical trial. Clinical periodontal parameters will be recorded and GCF samples will be collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
- Masking
- None (open label)
- Enrolment
- 21 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Zeyad Nazar
- Sponsor type
- University, hospital or other
- Collaborators
- Babylon University
- Responsible party
- Sponsor-investigator, Zeyad Nazar, Babylon University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07596667
- Sponsor's protocol ID
- BabylonU
- Status last verified
- May 2026
- First submitted
- 7 May 2026
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Vitkov L, Singh J, Schauer C, Minnich B, Krunic J, Oberthaler H, Gamsjaeger S, Herrmann M, Knopf J, Hannig M. Breaking the Gingival Barrier in Periodontitis. Int J Mol Sci. 2023 Feb 25;24(5):4544. doi: 10.3390/ijms24054544.
PubMed 36901974
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial
- ClinicalTrials.gov ID
- NCT07596667
- Acronym / sponsor ID
- BabylonU
- Conditions
- Periodontitis, Adult, Periodontal Diseases
- Keywords
- periodontitis, non surgical periodontal therapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 21 participants (estimated)
- Lead sponsor
- Zeyad NazarUniversity, hospital or other
- Collaborators
- Babylon University
- Study start
- 15 Jul 2026 (estimated)
- Primary completion
- 15 Nov 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Detailed description
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Keywords: periodontal diseases; periodontal debridement; dental polishing; periodontal pocket
Why is this important?
This research explained the effects of non surgical periodontal treatment for patients with periodontal disease on the epithelial tissue regeneration during the healing process.
Introduction Periodontitis is a destructive disease of tooth-supporting tissues which initiated in response to frank dysbiosis of dental biofilm complemented by aggravated immune response. The hallmark of periodontitis is pathologic deepening of gingival sulci which are transformed into periodontal pockets when the front of dental biofilm advances apically. In such situation, immune responses are initiated within gingival tissue in order to counterattack the pathobionts and its virulent products . Polymorph nuclear cells, mainly neutrophils, are among the principle immune system components responsible for this task via series of biological activities such as phagocytosis and netosis. Prolonged inflammation of periodontal lesions and continuous heavy recruitment of these inflammatory cells leads to the release of oxygen free radicals (ROS) in an escalating pace which overwhelm antioxidant capacity of the host . Overproduction of ROS trigger series of destructive events characterized by increased metabolites of lipid peroxidation, DNA damage and protein damage that led to tissues damage . This shift of oxidative-antioxidant balance towards oxidative stress leads to dramatic changes in the levels of oxidative stress-related molecules such as total antioxidant capacity (TAC) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) . These biomarkers can be clinically detected in oral biofluids such as saliva and GCF with a potential to discriminate between periodontal health and disease .
In healthy periodontium, the gingival sulcus is lined by sulcular epithelium which is continued with the junctional epithelium at sulcus base. The epithelial cells are adherent to each other by range of junctional attachment including desmosomes, adherens junctions, and tight junctions. The integrity of this coherent epithelial cells provides a physical barrier against the ingress of pathobionts to deeper tissues or systemic circulation. Adherens junctions is the predominant cellular junctions which structurally composed of E-cadherin that grouped in extracellular, transmembrane, and intracellular domains. β-catenin forms a complex with E-cadherin, mediating the attachment of intracellular domain of adherens junctions to the cytoskeleton . Persistent inflammation associated with excessive oxidative stress culminating in the tissue compromises epithelial barrier function . Damage of E-cadherin-β-catenin complex leads to the release of β-catenin and its subsequent nuclear translocation; thereby, activating Wnt signaling pathway which is responsible for compromising epithelial phenotype . This notion is supported by detecting elevated level of β-catenin in GCF samples collected from periodontitis patients associated with clinical attachment loss (CAL) in comparison to healthy controls .
The goal of periodontal therapy is to preserve and maintain natural dentition as well as improve oral and systemic health. Non-surgical periodontal therapy (NSPT) considered as gold standard decision to remove biofilm and reduce pathobionts load to restore symbiotic state of oral microbiome and tissue homeostasis . Demand of Successful periodontal therapy depends on improvement in clinical parameters in the term of bleeding on probing (BOP), probing pocket depth (PPD) and CAL . Therefore, this study aimed to track changes in the level GCF of β-catenin ,8-OHdG, and TAC and investigate the association between these biomarkers during the healing period.
Materials and methods Study design This study is a clinical trial involving periodontitis patients who will followed for up to 3 months. The study will conducted from June 2026 to September 2026. The participants will be selected from the pool of patients attending the clinics in the College of Dentistry, University of Babylon. The volunteered patients should sign consent form, which will be collected by the examiner.
Inclusion and exclusion criteria The patients should be ≥ 18 years, have no history of systemic disease, have unstable periodontitis at any stage and grade with at least one moderately deep periodontal pocket (4 - 6 mm) at a single-rooted tooth. The patients were excluded when they were smokers, pregnant or lactating, taking medications which might influence the healing such as corticosteroids and calcium channel blockers, having previous periodontal therapy within the last 3 months, or using antibiotics within 3 months prior to enrolment.
Sample size The required sample size for this study was estimated after considering a reduction in probing pocket depth (PPD) from 7.64 ±1.76 mm to 5.68 ±2.3 mm in shallow pockets [12]. By using G*Power software 3.1, it was estimated that a sample of 17 patients was enough for rejecting the null hypothesis at a power of 0.8 and probability margin of error of 0.05. An extra four patients were invited to participate in this study to avoid any dropout during the follow-up.
Clinical examination and procedure At baseline visit (T0), the selected patients will diagnosed with unstable periodontitis which will defined by the presence of interdental clinical attachment loss (CAL) at ≥ 2 non-adjacent teeth and PPD > 5 mm or 4 mm pockets with bleeding on probing (BOP). In absence of interdental CAL, patients having buccal or oral CAL ≥ 3 mm with PPD > 3 mm detectable at ≥ 2 teeth were also diagnosed as periodontitis [13]. After diagnosis, plaque Index (PI) will used to record presence/absence of dental plaque on 4 sites/tooth with the aid of disclosing agent (EMS®, Switzerland) [14]. Then, BOP, PPD and CAL will recorded at 6 sites/tooth using UNC-15 periodontal probe (PHOENIX®, UK) by a calibrated examiner.
GCF samples will collected from randomly selected sites with periodontal pockets of 4 -6 mm after recording the clinical parameters. Each site will dried using cotton and air blowing by triple syringe. A paper strip (Oraflow Inc.®, New York, USA) will inserted into the selected pocket until feeling slight resistance. After 30 seconds, this pre-weighted paper strip will removed and immediately immersed in an Eppendorf tube (CNWTC/OEM, Jiangsu, China) containing 200 µl phosphate buffer saline (PBS) [15]. Then, the tube containing the strip and PBS will weighted using an electronic balance (JOANLAB®, China). The GCF weight will estimated by subtracting the weight of the tube containing the strip and PBS after sampling from the weights of the dry strip and the tube with PBS before sampling the GCF. Then, the tubes containing GCF samples will saved at -20 °C until further analysis.
After GCF samples collection, patients will receive professional mechanical plaque removal (PMPR) using ultrasonic scaler by the same examiner. Finally, oral hygiene instructions will given to all patients including tooth brushing twice a day and interdental cleaning with an appropriate tool such as interdental brush and dental floss. One week later, root surface debridement (RSD) will performed for all sites with pockets with Gracey curettes (Sakura, YDM®, Japan). Then, all teeth will polished by rubber cups and prophylaxis paste. After 4 weeks (T1) and 12 weeks (T2), all clinical parameters will recorded and GCF samples will recollected as describe above by the same examiner.
Enzyme-linked immunosorbent assay The frozen GCF samples will thawed at room temperature and centrifuged at 4000 RPM for 5 min (Rotofix® 32A, Germany). The optical density will measured at 450 nm and the operator who performed the procedures will blinded to the tested groups. Concentration of 8-OHdG was quantified competitive inhibition enzyme immunoassay technique (USCN®, USA). Sensitivity values was 26.81 pg/ml, with a detection range of 74.07-6.000 pg./ml. ELISA-based sandwich technique will used for quantitative measurement of β-catenin kit (USCN®, USA) with sensitivity values was 5.9 pg./ml and detection range of15.6-1.000 pg/ml. Colorimetric assay facilitated by an ELISA TAC kit (Elabscience®, USA) sensitivity value was 0.62 U/ml with detection range 0.62-190.43 U/ml.
Statistical analysis Data will analyzed using Prism 9 for macOS (Version 9.1.1) and IBM SPSS Statistics (Version 27). Data will presented as frequency, percentage or means (SD). The normality of continuous data will tested using Shapiro-Wilk test. Comparisons among means of variables at different time points will carried out using Friedman test. Dunn's test was used for Post hoc comparison between means of variables at two time points with consideration of adjusting considered p value. Pearson test and linear regression will used to assess the association and possible interactions between the study variables. The significance level will set at p value < 0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Periodontitis patients (n = 21) will be included in this clinical trial. Clinical periodontal parameters will be recorded and GCF samples will be collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
| Arm | Type | Receives |
|---|---|---|
| periodontitis patients with pocket depth | Experimental | Procedure: scaling and root planing |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- patients over 18 years old
- patients with periodontal pockets depth more than 4 mm
Key exclusion criteria (3 listed)
- Pregnant women
- patients taking antibiotic within the last three months
- Patients with systemic disease ( Diabetes mellitus)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| scaling and root planingPeriodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA). | Procedure or surgery | periodontitis patients with pocket depth |
Primary outcome
periodontal pocket depth
Time frame: 3 months
periodontal pocket depth reduction
measurement of probing pocket depth (PPD)
Time frame: 3 months
measuring probing pocket depth (PPD)
measurement of clinical attachment loss (CAL)
Time frame: 3 months
clinical attachment loss (CAL)
1 secondary outcome
GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA) in which all have the same measuring units
Time frame: 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Background: PubMed 36901974Vitkov L, Singh J, Schauer C, Minnich B, Krunic J, Oberthaler H, Gamsjaeger S, Herrmann M, Knopf J, Hannig M. Breaking the Gingival Barrier in Periodontitis. Int J Mol Sci. 2023 Feb 25;24(5):4544. doi: 10.3390/ijms24054544.
- Individual participant dataSharing planned: Undecided
Related trials for Periodontitis, Adult
RecruitingObservational study
Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years
Diabete Mellitus, Dyslipidaemia
RecruitingObservational study
Evaluation of Masticatory Performance in Patients With Periodontitis
Periodontitis, Adult, Periodontitis
Not yet recruitingObservational study
Evaluation of Changes in Oral Health-related Quality of Life During the Treatment of Periodontitis.
Periodontitis, Adult, Periodontitis
Not yet recruiting
Sonic Irrigation Activation for Postoperative Pain After Root Canal Treatment
Asymptomatic Apical Periodontitis
Active, not recruiting
Utilization of a Videoscope in Periodontal Regeneration
Chronic Periodontitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing scaling and root planing in people with Periodontitis, Adult and Periodontal Diseases, run by Zeyad Nazar.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
periodontal pocket depth (time frame: 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07596667, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.